Association between GRK4 and DRD1 gene polymorphisms and hypertension: a meta-analysis

Area of Science:

• Genetics
• Cardiovascular Disease
• Pharmacogenomics

Background:

• The genetic underpinnings of hypertension are complex and not fully understood.
• The roles of GRK4 (G protein-coupled receptor kinase 4) and DRD1 (Dopamine D1 receptor) genes in hypertension etiology are debated.
• Polymorphisms in these genes are potential candidates for influencing hypertension susceptibility.

Purpose of the Study:

• To conduct a meta-analysis investigating the association between GRK4 and DRD1 gene polymorphisms and hypertension risk.
• To explore the relationship between genetic variations in GRK4 and DRD1 and the development of hypertension.
• To examine ethnic-specific effects of these polymorphisms on hypertension.

Main Methods:

• Systematic retrieval and selection of relevant case-control studies from multiple databases.
• Meta-analysis using odds ratios (ORs) and 95% confidence intervals (CIs) to quantify genetic associations.
• Subgroup analyses based on ethnicity and sensitivity analyses to assess the robustness of findings.

Main Results:

• The DRD1 rs4532 polymorphism was significantly associated with an increased risk of hypertension (OR = 1.353).
• The GRK4 rs1024323 polymorphism was linked to hypertension in Caucasians (OR = 1.826) but not in other ethnic groups.
• The DRD1 rs4532 polymorphism showed an association with hypertension in East Asians (OR = 1.833) but not in Caucasians.

Conclusions:

• This meta-analysis provides evidence that specific polymorphisms in the GRK4 and DRD1 genes are associated with hypertension risk.
• Ethnic differences exist in the contribution of GRK4 rs1024323 and DRD1 rs4532 to hypertension susceptibility.
• These findings may guide future research and clinical investigations into hypertension genetics.